跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,937 条关于
“Actuate”
全部
26,937
临床试验
26,174
药物
368
机构
4
资讯
391
3年前
Elraglusib Receives FDA Orphan Drug Designation for Pancreatic Cancer Treatment
2年前
Actuate Therapeutics' Elraglusib Shows Promise in Relapsed/Refractory Ewing Sarcoma Trial
去年
Actuate Therapeutics and Lantern Pharma Collaborate on AI-Driven Elraglusib Development
去年
Actuate Therapeutics' Elraglusib Shows Promise in Pancreatic Cancer as IPO Lock-up Expires
去年
Elraglusib Receives EMA Orphan Drug Designation for Pancreatic Cancer Treatment
去年
Lantern Pharma Highlights AI-Driven Oncology Drug Development in Upcoming Webinars
去年
Elraglusib Plus Chemotherapy Shows Promise in Metastatic Pancreatic Cancer
去年
Actuate Therapeutics Reports Significant Survival Improvement in Metastatic Pancreatic Cancer Phase 2 Trial
9个月前
Actuate Therapeutics Reports Positive Phase II Results for Elraglusib in Advanced Salivary Gland Cancers
2年前
Elraglusib Receives FDA Orphan Drug Designation for Soft Tissue Sarcoma
第 1 页,共 40 页
上一页
下一页